Clinac 4/100
510(k) K771808
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK771808 | Date19 Oct 1977 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- IYE
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.5050
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 28 Sep 2026
This device is a linear accelerator used in medical applications, specifically classified as an Accelerator, Linear, Medical under FDA device classification. It was determined to be substantially equivalent through a traditional 510(k) clearance process.
The Clinac 4/100 received FDA 510(k) clearance under K771808 on October 19, 1977, and is manufactured by Varian Assoc., Inc. It is classified under product code IYE and regulation number 892.5050, with the device falling under the radiology medical specialty and advisory committee classification.
Other devices from Varian Assoc., Inc.
Questions
AI-generated answers, 28 Sep 2026
What is the Clinac 4/100 used for?
The Clinac 4/100 is a linear accelerator used in medical applications, specifically for delivering radiation therapy in oncology treatment. It is classified under the radiology medical specialty and is designed to generate high-energy X-rays or electron beams for targeted tumor treatment, as indicated by its FDA classification as an Accelerator, Linear, Medical.
Who manufactures the Clinac 4/100 and where is it made?
The Clinac 4/100 is manufactured by Varian Assoc., Inc., with the applicant and manufacturer listed as Varian Assoc., Inc. The device’s registration and FEI numbers include multiple entries associated with Varian facilities, and the address on file is 803 N. Front St. Suite 3, Mchenry, IL 60050, United States.
How was the Clinac 4/100 cleared for market release?
The Clinac 4/100 received FDA 510(k) clearance through a traditional submission process under K771808, with a decision date of October 19, 1977. It was determined to be substantially equivalent (SESE) to a legally marketed predicate device, which allowed it to be cleared for commercial distribution without requiring a premarket approval application.